Simulations Plus, Inc. $SLP Shares Sold by Kopion Asset Management LLC

Kopion Asset Management LLC reduced its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 27.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 134,388 shares of the technology company’s stock after selling 51,006 shares during the quarter. Simulations Plus comprises about 1.8% of Kopion Asset Management LLC’s portfolio, making the stock its 18th largest holding. Kopion Asset Management LLC’s holdings in Simulations Plus were worth $2,450,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Raymond James Financial Inc. purchased a new stake in Simulations Plus during the 2nd quarter worth approximately $25,000. Quarry LP purchased a new position in shares of Simulations Plus in the third quarter worth $28,000. CWM LLC raised its holdings in shares of Simulations Plus by 3,729.1% in the third quarter. CWM LLC now owns 2,106 shares of the technology company’s stock worth $32,000 after buying an additional 2,051 shares during the last quarter. Farther Finance Advisors LLC acquired a new stake in shares of Simulations Plus during the third quarter worth $40,000. Finally, US Bancorp DE lifted its stake in shares of Simulations Plus by 32.5% during the third quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock worth $93,000 after buying an additional 1,513 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on SLP shares. TD Cowen reissued a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. Zacks Research cut Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. Citigroup reiterated a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Finally, BTIG Research lowered Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of “Hold” and a consensus target price of $25.00.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $11.71 on Friday. The stock has a market cap of $235.92 million, a PE ratio of -3.66 and a beta of 1.17. The firm has a fifty day moving average price of $14.91 and a 200 day moving average price of $16.25. Simulations Plus, Inc. has a 1 year low of $11.16 and a 1 year high of $36.45.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.05). The business had revenue of $18.42 million during the quarter, compared to analysts’ expectations of $18.05 million. Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. During the same period in the previous year, the company posted $0.17 earnings per share. As a group, equities analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.